Pim van Leeuwen
The Netherlands Cancer Institute, Università Cattolica del Sacro Cuore
Papers
2
Total Citations
13
H-Index
2
About
Pim van Leeuwen is a leading figure in the field of urologic oncology, with a specific focus on advancing surgical precision through novel imaging technologies. His research centers on the development and evaluation of hybrid tracers and detection probes for robot-assisted prostate cancer surgery. A key contribution is his work on fluorescence imaging at microdosing levels using a hybrid PSMA tracer, demonstrating its feasibility in a large animal model—a critical step toward enabling real-time visual confirmation during radioguided surgery. This work, published in 2022, has already garnered 11 citations, reflecting its immediate impact. Van Leeuwen has also pioneered the use of a DROP-IN beta probe for ⁶⁸Ga-PSMA radioguided surgery, conducting the first ex vivo evaluation on prostate cancer specimens. This innovation integrates beta-emitting PET isotopes with robotic platforms, offering a more sensitive alternative to traditional gamma probes. His contributions are shaping the next generation of targeted, image-guided interventions, bridging the gap between nuclear medicine and surgical robotics.
Research Focus
Key Achievements
Top Papers
- 1
- 2